1. Artificial pancreas systems for people with type 2 diabetes: Conception and design of the european CLOSE project
- Author
-
Björn Broge, Anton Petkov, Sébastien Carlier, Constance Stegbauer, Joachim Szecsenyi, Jan-Philipp Beck, Véronique Crône, Beata Mianowska, Mikolaj Gurdala, Cécile Delval, George Binkley, Pieter Gillard, Eric Renard, Lutz Heinemann, Volker Lodwig, Magda Rosenmöller, Freimut Schliess, Tim Heise, Katarzyna Cypryk, Chantal Mathieu, Carsten Benesch, Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, Diabetes Clinic, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génomique Fonctionnelle (IGF), and Université de Montpellier (UM)-Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Blood Glucose ,Pancreas, Artificial ,Service (systems architecture) ,Knowledge management ,homecare ,[SDV]Life Sciences [q-bio] ,Endocrinology, Diabetes and Metabolism ,digital health ,Biomedical Engineering ,030209 endocrinology & metabolism ,Bioengineering ,Interconnectedness ,Homecare ,Education ,03 medical and health sciences ,0302 clinical medicine ,Insulin Infusion Systems ,Stakeholder Participation ,Internal Medicine ,Animals ,Humans ,030212 general & internal medicine ,Closed-loop ,Review Articles ,closed-loop ,education ,business.industry ,Blood Glucose Self-Monitoring ,Equipment Design ,Service provider ,Digital health ,3. Good health ,public-private partnership ,Europe ,Public–private partnership ,Diabetes Mellitus, Type 1 ,Treatment Outcome ,Diabetes Mellitus, Type 2 ,Research Design ,General partnership ,Knowledge triangle ,Performance indicator ,France ,business ,Biomarkers ,Public-private partnership - Abstract
In the last 10 years tremendous progress has been made in the development of artificial pancreas (AP) systems for people with type 1 diabetes (T1D). The pan-European consortium CLOSE (Automated Glu cose Contro l at H ome for People with Chronic Disea se) is aiming to develop integrated AP solutions (APplus) tailored to the needs of people with type 2 diabetes (T2D). APplus comprises a product and service package complementing the AP system by obligatory training as well as home visits and telemedical consultations on demand. Outcome predictors and performance indicators shall help to identify people who could benefit most from AP usage and facilitate the measurement of AP impact in diabetes care. In a first step CLOSE will establish a scalable APplus model case working at the interface between patients, homecare service providers, and payers in France. CLOSE will then scale up APplus by pursuing geographic distribution, targeting additional audiences, and enhancing AP functionalities and interconnectedness. By being part of the European Institute of Innovation and Technology (EIT) Health public-private partnership, CLOSE is committed to the EIT "knowledge triangle" pursuing the integrated advancement of technology, education, and business creation. Putting stakeholders, education, and impact into the center of APplus advancement is considered key for achieving wide AP use in T2D care. ispartof: J Diabetes Sci Technol vol:13 issue:2 pages:261-267 ispartof: location:United States status: published
- Published
- 2019